Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial
Nakwon Kwak, Doosoo Jeon, Youngmok Park, Young Ae Kang, Kyung Jong Kim, Young Ran Kim, Byoung Soo Kwon, Yong Soo Kwon, Hyung Jun Kim, Jae Ho Lee, Ji Yeon Lee, Jung Kyu Lee, Jeongha Mok, Minkyoung Cheon, Jiwon Park, Seokyung Hahn, Jae Joon Yim
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial'. Together they form a unique fingerprint.